Nucleic acid respiratory syncytial virus vaccines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6017897
SERIAL NO

08896500

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Non-replicating vectors containing a nucleotide sequence coding for an F protein of respiratory syncytial virus (RSV) and a promoter for such sequence, preferably a cytomegalovirus promoter, are described for in vivo immunization. Such non-replicating vectors, including plasmids, also may contain a further nucleotide sequence located adjacent to the RSV F protein encoding sequence to enhance the immunoprotective ability of the RSV F protein when expressed in vivo. Such non-replicating vectors may be used to immunize a host against disease caused by infection with RSV, including a human host, by administration thereto, and may be formulated as immunogenic compositions with pharmaceutically-acceptable carriers for such purpose. Such vectors also may be used to produce antibodies for detection of RSV infection in a sample.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CONNAUGHT LABORATORIES LIMITED;PASTEUR MERIEUX CONNAUGHT CANADA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ewasyshyn, Mary E Willowdale, CA 23 140
Klein, Michel H Willowdale, CA 151 1224
Li, Xiaomao Thornhill, CA 16 129
Sambhara, Suryaprakash Markham, CA 15 86

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation